As conflicts erupt throughout the globe regarding so-called pay-for-delay schemes, in which a pharmaceutical company pays its generic counterpart to

The head of money markets for Barclays has reportedly accepted his involvement in the LIBOR scandal, reports say, as the

As MasterCard fights to maintain its cross-border swipe-fees throughout the EU, reports say the credit card giant’s efforts against authorities’

Reports say Canada’s gold miner Goldcorp will not likely face antitrust hurdles in its acquisition of rival miner Osisko Mining.

Australia’s second-largest department store David Jones revealed it had rejected a takeover offer last October by rival Myer Holdings, reports

After amendments to South Africa’s competition law came into effect last April, reports say the Competition Commission has announced its

Paper makers Verso Paper and NewPage Holdings said they may be forced to abandon $1.4 billion merger plans due to

Valeant Pharmaceuticals has major plans for 2014, including the goal of becoming one of the world’s five-largest pharmaceutical companies. That